novartis - Latest News on novartis | Read Breaking News on Zee News

Novartis cites momentum in 3% profit rise

Last Updated: Thursday, July 17, 2014, 15:10

Novartis is selling its animal health division to Eli Lilly for about USD 5.4 billion, in a deal it said on Thursday is now expected to close in the first quarter of 2015.

Novartis Japan unit charged over research manipulation

Last Updated: Tuesday, July 01, 2014, 15:16

In April, Novartis replaced the top executives at its Japanese arm over those allegations.

Ranbaxy gets FDA approval for Novartis' Diovan generic

Last Updated: Friday, June 27, 2014, 09:39

Ranbaxy will be the first rival drugmaker to launch a copy of Diovan in the United States and will be entitled to six months of exclusivity to sell it.

Italy seeks 1.2 bn euros in anti-trust damages from Roche, Novartis

Last Updated: Thursday, May 29, 2014, 04:32

Italy`s health ministry is seeking 1.2 billion euros ($1.6 million) in compensation from Swiss pharma giants Novartis and Roche for the manipulation of sales of a cheap drug used to treat eye problems, Italian media reported Wednesday.

Sun Pharma settles litigation with Novartis over cancer drug

Last Updated: Thursday, May 15, 2014, 09:40

Sun Pharma`s subsidiary holds a tentative approval from the U.S Food and Drug Administration for a generic version of Gleevec.

Pharma giant Novartis sees net profit jump 24%

Last Updated: Thursday, April 24, 2014, 15:04

Swiss pharmaceuticals giant Novartis on Thursday posted a 24-percent jump in first-quarter net profit, driven largely by the sale of a blood transfusion diagnostics unit.

Earnings, big pharma deals give S&P 500 6th straight gain

Last Updated: Wednesday, April 23, 2014, 10:54

Solid earnings and major pharmaceutical-sector deals lifted stocks Tuesday, producing a sixth straight day of gains for the S&P 500 and Nasdaq Composite Index.

GSK-Novartis global deal not to impact India business: GSKCH

Last Updated: Tuesday, April 22, 2014, 19:13

GlaxoSmithKline Consumer Healthcare shares closed at Rs 4,368 on the BSE, up 0.06 percent.

Novartis buys GSK's cancer drugs for $16 bn in three-part deal

Last Updated: Tuesday, April 22, 2014, 19:10

UK-headquartered GSK will have majority control with an equity interest of 63.5 per cent in the venture.

Novartis India shares surge 20% in intra-day on GSK deal

Last Updated: Tuesday, April 22, 2014, 18:49

Shares of Novartis India on Tuesday surged 20 percent in intra-day as global pharma major Novartis will acquire GlaxoSmithKline plc's cancer drugs portfolio for USD 16 billion and sell its vaccines business in return for USD 7.1 billion.

Novartis shares rally after multibillion-dollar deals with GSK, Lilly

Last Updated: Tuesday, April 22, 2014, 14:55

In Mumbai, Novartis India also climbed by 7.36 percent to 501.95 on BSE.

Novartis transforms drugs business via deals with GSK and Lilly

Last Updated: Tuesday, April 22, 2014, 14:24

Novartis is transforming its business by exchanging certain assets with GlaxoSmithKline and divesting its animal health business to Eli Lilly.